Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis

Parasitology Research

Volumn 111, Issue 4, 2012, Pages 1807-1816

  Valadares, Diogo G ^a   Duarte, Mariana C ^b   Ramírez, Laura ^c   Chávez Fumagalli, Miguel A ^a   Lage, Paula S ^a   Martins, Vivian T ^a   Costa, Lourena E ^a   Ribeiro, Tatiana G ^a   B Régis, Wiliam C ^d,e   Soto, Manuel ^c   Fernandes, Ana Paula ^a   Tavares, A P Carlos ^a   Coelho, Eduardo A F ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Departamento de Patologia Clínica   (Brazil)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Minasfungi do Brasil Ltda   (Brazil)

^e PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI EXTRACT; AMPHOTERICIN B; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 4; NITRIC OXIDE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE TITRATION; FEMALE; FOOT PAD; INFLAMMATION; LEISHMANIA; LEISHMANIASIS; LIVER TOXICITY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; AGARICUS; ANIMALS; ANTIPROTOZOAL AGENTS; BIOLOGICAL AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FOOT; HUMANS; LEISHMANIA; LEISHMANIASIS; LIVER; LYMPH NODES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PARASITE LOAD; TREATMENT OUTCOME;

AGARICUS BLAZEI; ANIMALIA; LEISHMANIA AMAZONENSIS; MAMMALIA; MUS;

EID: 84868198802     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-012-3028-1     Document Type: Article

References (32)

1. Afonso LC, Scott P (1993) Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61:2952-2959
2. Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LAM (2009) Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens. J Antimicrob Chemother 64:1234-1240
3. Aguiar MG, Pereira AMM, Fernandes AP, Ferreira LAM (2010) Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis. Antimicrob Agents Chemother 54:4699-4704
4. Balaraman S, Tewary P, Singh VK, Madhubala R (2004) Leishmania donovani induces interferon regulatory factor in murine macrophages: a host defense response. Biochem Biophys Res Commun 317:639-647
5. Barral A, Pedral-Sampaio D, Grimaldi G Jr, Momen H, McMahon- Pratt D, Ribeiro-de-Jesus A, Almeida R, Badaró R, Barral-Netto M, Carvalho EM, Johnson WD Jr (1991) Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. AmJTrop Med Hyg 44:536-546
6. Berman J (2003) Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 16:397-401
7. Berman F (2005) Clinical status of agents being developed for leishmaniasis. Expert Opin Invest Drugs 14:1337-1346
8. Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AM, Johnson E (2005) An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation 29:147-153
9. Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AMA, Johnson E (2006) An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation 29:147-153
10. Bernardshaw S, Lyberg T, Hetland G, Johnson E (2007) Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo. APMIS 115:719-725
11. Coelho EAF, Tavares CAP, Carvalho FAA, Chaves KF, Teixeira KN, Rodrigues RC, Matlashewski G, Gazzinelli RT, Fernandes AP (2003) Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71:3988-3994
12. Croft SL, Coombs GH (2003) Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 19:502-508
13. Croft SL, Olliaro P (2011) Leishmaniasis chemotherapy-challenges and opportunities. Clin Microbiol Infect 17:1478-1483
14. Cupolilo SM, Souza CS, Abreu-Silva AL, Calabrese KS, Goncalves da Costa SC (2003) Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol Histopathol 18:1059-1065
15. Forland DT, Johnson E, Tryggestad AM, Lyberg T, Hetland G (2010) An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro. Cytokine 49:245-250
16. Frézard F, Demicheli C (2009) New delivery strategies for the old pentavalent antimonial drugs. Expert Opin DrugDeliv 7:1343-1358
17. Grimaldi G Jr, Tesh RB (1993) Leishmaniases of the New World: current concepts and implications for future research. ClinMicrobiol Rev 6:230-250
18. Hsu CH, Hwang KC, Chiang YH, Chou P (2008) The mushroom Agaricus blazei Murill extract normalizes liver function in patients with chronic hepatitis B. J Altern Complement Med 14:299-301
19. Kedzierski L, Sakthianandeswaren A, Curtis JM, Andrews PC, Junk PC, Kedzierska K (2009) Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem 16:599-614
20. Kim YW, Kim KH, Choi HJ, Lee DS (2005) Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett 27:483-487
21. Kim CF, Jiang JJ, Leung KN, Fung KP, Lau CB (2009) Inhibitory effects of Agaricus blazei Murill extracts on human myeloid leukemia cells. J Ethnopharmacol 122:320-326
22. Mondal S, Bhattacharya P, Rahaman M, Ali N, Goswami RP (2010) A curative immune profile one week after treatment of Indian kalaazar patients predicts success with a short-course liposomal amphotericin B therapy. PLoS Negl Trop Dis 27:e764
23. Oliveira LF, Schubach AO, Martins MM, Passos SL, Oliveira RV, Marzochi MC, Andrade CA (2011) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 118:87-96
24. Padigel UM, Alexander J, Farrell JP (2003) The role of interleukin-10 in susceptibility of BALB/c mice to infectionwith Leishmania mexicana and Leishmania amazonensis. J Immunol 171:3705-3710
25. Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, Yamazaki S (2001) Secretion TNF-α, IL-12 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct Funct 26:103-108
26. Talcott JA, Clark JA, Lee IP (2007) Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei Murill: a survey of Japanese consumers with cancer. BMC Complement Alternat Med 29:7-32
27. Tang NY, Yang JS, Lin JP, Hsia TC, Fan MJ, Lin JJ,Weng SW,Ma YS, Lu HF, Shen JJ, Lin JG, Chung JG (2009) Effects of Agaricus blazei Murill extract on immune responses in normal BALB/c mice. In Vivo 23:761-766
28. Valadares DG, Duarte MC, Oliveira JS, Chávez-Fumagalli MA, Martins VT, Costa LE, Leite JPV, Santoro MM, Régis WCB, Tavares CAP, Coelho EAF (2011) Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Parasitol Int 60:357-363
29. Van Assche T, Deschacht M, Da Luz RA, Maes L, Cos P (2011) Leishmania-macrophage interactions: insights into the redox biology. Free Radic Biol Med 51:337-351
30. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827-835
31. World Health Organization (2000) The disease and its impact. http://who.int/emc/diseases/leish/index.html
32. Wu MF, Hsu YM, Tang MC, Chen HC, Chung JG, Lu HF, Lin JP, Tang NY, Yeh C, YehMY(2011) Agaricus blazeiMurill extract abrogates CCl4-induced liver injury in rats. In Vivo 25:35-40